This is reassuring since the majority of neoplasms that do not carry driver alterations within strong epigenomic modifiers (e.g., IDH1/2, SMARCB1) largely retain epigenomic features of their precursor lineages [17]. Here, SMARCB1 is linked to neoplasm.